🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsHas anyone dealt with how far away are we really from an oral option? Page 3

Has anyone dealt with how far away are we really from an oral option?

emily_PDX Sun, Jan 4, 2026 at 9:17 AM 17 replies 969 viewsPage 3 of 4
adam_van
Member
212
890
Nov 2024
Vancouver, CA
Jan 6, 2026 at 2:52 PM#11
Dr.DermMIA said:
Orforglipron is the more interesting oral story because it is not a peptide at all.

This is exactly what I could not find anywhere else. I will report back once I have actually tried it.

Last edited: Jan 6, 2026 at 6:52 PM
15 15FranDenver, Dr.BariatricHTX, LindaRN_retired and 12 others
Reply Quote Save Share Report
Dr.BariatricHTX
Senior Member
1,456
7,234
Feb 2024
Houston, TX
Jan 7, 2026 at 1:22 AM#12

Adding the clinical framing, because it changes how the question reads. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

Last edited: Jan 7, 2026 at 7:22 AM
14 14pete_RVA, CarlaRPh_TPA, steph_laguna and 11 others
Reply Quote Save Share Report
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
Jan 7, 2026 at 11:52 AM#13
Dr.KarenChen said:
Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent…

This is where I part company with the consensus forming above. Filing an objection on the n=1 problem. Personal experience is genuine evidence about one person and very weak evidence about anybody else, and this thread keeps promoting the first into the second.

Last edited: Jan 7, 2026 at 2:52 PM
13 13DataDave, Dr.GutHealth, amsterdam_pete and 10 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
wendy_avl
Member
245
1,123
Oct 2024
Asheville, NC
Jan 7, 2026 at 10:22 PM#14

One concrete data point for the thread. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

12 12PharmHunterJen, TomTeleRx, DoseLogDan and 9 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Jan 8, 2026 at 8:53 AM#15

Moderator note: the sourcing question belongs in the vendor section and has been split out.

11 11PurityPaulOR, MaxMetOK, MounjBrad and 8 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register